Middleton P G, Pollard K A, Wheatley J R
Dept of Respiratory Medicine, Westmead Hospital, NSW, Australia.
Eur Respir J. 2001 Feb;17(2):195-9. doi: 10.1183/09031936.01.17201950.
Aerosolized hypertonic saline is currently being investigated as a new agent for the treatment of impaired mucociliary clearance which occurs in many respiratory diseases. Mannitol aerosols, in particular dry powder inhalers, have been proposed as an alternative treatment to saline, offering the same osmotic load with other benefits. However, the effects of these hypertonic aerosols on airway epithelial ion transport processes have not been tested in human subjects in vivo. This report examines the effect of these solutions on airway ion transport using the nasal potential difference (PD) technique. Seven healthy nonsmoking adult volunteers were studied. On different days, a dose-response curve was constructed for the saline added to Krebs N-[2-hydroxyethyl] piperazine-N'-[2-ethanesulphonic acid] (HEPES) diluent. The reversibility of this saline effect was measured, and the response to additional saline (500 mM) and mannitol (1 M) compared. Hypertonic saline decreased nasal PD in a dose-related manner, with mean (SEM) decreases in PD (less negative) of 6.6 (1.5), 7.6 (1.6), 10.0 (2.0), 13.1 (2.9) and 14.8 (3.2) mV (n =4) for addition of 150 mM, 250 mM, 500 mM, 1,200 mM and 2,000 mM NaCl to the Krebs HEPES diluent, respectively. The effect of hypertonic saline was fully reversible with washout for 3 min (presaline 15.9 (0.5) mV, postwashout 15.8 (1.1) mV, (n=4)). The hypertonic saline response was rapid in onset, sustained for at least 4 min, and decreased PD from 13.7 (1.7) mV to 5.1 (1.3) mV (n = 7, p < 0.001). In contrast, addition of mannitol to the perfusate did not significantly alter nasal PD, with a nonsignificant trend towards an increase (more negative) in the PD, (premannitol 13.9 (1.6) mV, postmannitol 15.3 (2.0) mV, n=7). As the osmotic stimulus of the 1 M mannitol is similar to that of the 500 mM sodium chloride, the divergent nasal potential difference responses suggest that the response to the saline was specific to the sodium chloride itself and not the simultaneous change in osmolarity. This demonstrates that the human airway epithelium in vivo can respond to topical hypertonic saline independent of the altered osmolarity.
雾化高渗盐水目前正作为一种新型药物进行研究,用于治疗多种呼吸系统疾病中出现的黏液纤毛清除功能受损。甘露醇气雾剂,特别是干粉吸入器,已被提议作为盐水的替代治疗方法,它能提供相同的渗透负荷并具有其他益处。然而,这些高渗气雾剂对气道上皮离子转运过程的影响尚未在人体进行体内测试。本报告使用鼻电位差(PD)技术研究了这些溶液对气道离子转运的影响。研究了7名健康的非吸烟成年志愿者。在不同日期,构建了添加到 Krebs N-[2-羟乙基]哌嗪-N'-[2-乙磺酸](HEPES)稀释剂中的盐水的剂量反应曲线。测量了这种盐水作用的可逆性,并比较了对额外盐水(500 mM)和甘露醇(1 M)的反应。高渗盐水以剂量相关的方式降低鼻PD,向 Krebs HEPES 稀释剂中分别添加150 mM、250 mM、500 mM、1200 mM 和 2000 mM NaCl 后,PD(负值减小)的平均(SEM)降低分别为6.6(1.5)、7.6(1.6)、10.0(2.0)、13.1(2.9)和14.8(3.2)mV(n = 4)。高渗盐水的作用在冲洗3分钟后完全可逆(冲洗前15.9(0.5)mV,冲洗后15.8(1.1)mV,(n = 4))。高渗盐水反应起效迅速,持续至少4分钟,使PD从13.7(1.7)mV降至5.1(1.3)mV(n = 7,p < 0.001)。相比之下,向灌注液中添加甘露醇并未显著改变鼻PD,PD有不显著的增加趋势(更负)(添加甘露醇前13.9(1.6)mV,添加甘露醇后15.3(2.0)mV,n = 7)。由于1 M甘露醇的渗透刺激与500 mM氯化钠相似,鼻电位差反应的差异表明对盐水的反应特定于氯化钠本身,而非渗透压同时变化。这表明体内人体气道上皮可独立于渗透压改变对局部高渗盐水作出反应。